2021 Q4 Form 10-Q Financial Statement

#000140658722000010 Filed on January 28, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $407.6M $307.1M
YoY Change 32.73% 24.23%
Cost Of Revenue $334.2M $262.9M
YoY Change 27.12% 21.38%
Gross Profit $73.40M $44.20M
YoY Change 66.06% 44.44%
Gross Profit Margin 18.01% 14.39%
Selling, General & Admin $21.50M $15.50M
YoY Change 38.71% 47.62%
% of Gross Profit 29.29% 35.07%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $800.0K $800.0K
YoY Change 0.0% -57.89%
% of Gross Profit 1.09% 1.81%
Operating Expenses $21.50M $15.50M
YoY Change 38.71% 47.62%
Operating Profit $51.90M $28.70M
YoY Change 80.84% 42.79%
Interest Expense $1.100M $500.0K
YoY Change 120.0% -77.27%
% of Operating Profit 2.12% 1.74%
Other Income/Expense, Net
YoY Change
Pretax Income $53.50M $29.20M
YoY Change 83.22% 31.53%
Income Tax $13.00M $7.100M
% Of Pretax Income 24.3% 24.32%
Net Earnings $40.50M $22.00M
YoY Change 84.09% 30.18%
Net Earnings / Revenue 9.94% 7.16%
Basic Earnings Per Share $0.81 $0.46
Diluted Earnings Per Share $0.81 $0.46
COMMON SHARES
Basic Shares Outstanding 49.68M shares 48.13M shares
Diluted Shares Outstanding 49.73M shares 48.19M shares

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.5M $237.4M
YoY Change -31.55% -36.41%
Cash & Equivalents $162.5M $237.4M
Short-Term Investments
Other Short-Term Assets $12.50M $3.000M
YoY Change 316.67% 25.0%
Inventory
Prepaid Expenses
Receivables $2.100M $300.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $177.1M $240.7M
YoY Change -26.42% -36.12%
LONG-TERM ASSETS
Property, Plant & Equipment $4.200M $1.900M
YoY Change 121.05% 111.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $500.0K $1.000M
YoY Change -50.0% -83.05%
Other Assets
YoY Change
Total Long-Term Assets $1.985B $1.569B
YoY Change 26.58% 42.19%
TOTAL ASSETS
Total Short-Term Assets $177.1M $240.7M
Total Long-Term Assets $1.985B $1.569B
Total Assets $2.163B $1.809B
YoY Change 19.53% 22.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $53.50M $42.20M
YoY Change 26.78% 113.13%
Accrued Expenses $148.0M $66.10M
YoY Change 123.9% 3.93%
Deferred Revenue $3.700M $0.00
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $363.3M $228.1M
YoY Change 59.27% 31.77%
LONG-TERM LIABILITIES
Long-Term Debt $704.9M $654.1M
YoY Change 7.77% 41.55%
Other Long-Term Liabilities $11.70M $25.00M
YoY Change -53.2% 155.1%
Total Long-Term Liabilities $716.6M $679.1M
YoY Change 5.52% 43.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $363.3M $228.1M
Total Long-Term Liabilities $716.6M $679.1M
Total Liabilities $1.104B $915.1M
YoY Change 20.65% 39.86%
SHAREHOLDERS EQUITY
Retained Earnings $369.6M $240.9M
YoY Change 53.42% 37.66%
Common Stock $687.8M $652.2M
YoY Change 5.46% 0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.057B $893.1M
YoY Change
Total Liabilities & Shareholders Equity $2.163B $1.809B
YoY Change 19.53% 22.25%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income $40.50M $22.00M
YoY Change 84.09% 30.18%
Depreciation, Depletion And Amortization $800.0K $800.0K
YoY Change 0.0% -57.89%
Cash From Operating Activities $5.800M -$158.7M
YoY Change -103.65% 1268.1%
INVESTING ACTIVITIES
Capital Expenditures $1.500M $100.0K
YoY Change 1400.0%
Acquisitions
YoY Change
Other Investing Activities $4.700M $2.100M
YoY Change 123.81% -32.26%
Cash From Investing Activities $3.200M $2.000M
YoY Change 60.0% -35.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$100.0K -$200.0K
YoY Change -50.0% -80.0%
NET CHANGE
Cash From Operating Activities $5.800M -$158.7M
Cash From Investing Activities $3.200M $2.000M
Cash From Financing Activities -$100.0K -$200.0K
Net Change In Cash $8.900M -$156.9M
YoY Change -105.67% 1551.58%
FREE CASH FLOW
Cash From Operating Activities $5.800M -$158.7M
Capital Expenditures $1.500M $100.0K
Free Cash Flow $4.300M -$158.8M
YoY Change -102.71% 1268.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001406587
CY2021Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2021Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q4 dei Amendment Flag
AmendmentFlag
false
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherLiabilities
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
001-33662
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
FORESTAR GROUP INC.
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1336998
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
2221 E. Lamar Blvd.
CY2021Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 790
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Arlington
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76006
CY2021Q4 dei City Area Code
CityAreaCode
817
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
769-1860
CY2021Q4 dei Security12b Title
Security12bTitle
Common Stock, par value $1.00 per share
CY2021Q4 dei Trading Symbol
TradingSymbol
FOR
CY2021Q4 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49675768 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162500000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153600000 USD
CY2021Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1960100000 USD
CY2021Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1905200000 USD
CY2021Q4 us-gaap Equity Method Investments
EquityMethodInvestments
500000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
900000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4200000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2900000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
35200000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
39100000 USD
CY2021Q4 us-gaap Assets
Assets
2162500000 USD
CY2021Q3 us-gaap Assets
Assets
2101700000 USD
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
53500000 USD
CY2021Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
47400000 USD
CY2021Q4 for Accrued Development Costs
AccruedDevelopmentCosts
116700000 USD
CY2021Q3 for Accrued Development Costs
AccruedDevelopmentCosts
104500000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
141900000 USD
CY2021Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
148300000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24200000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24400000 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
62900000 USD
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
56700000 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
704900000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
704500000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
1104100000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
1085800000 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49675768 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49580389 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
49700000 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
49600000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
638100000 USD
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
636200000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
369600000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
329100000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1057400000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1014900000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
1000000.0 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
1000000.0 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1058400000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1015900000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2162500000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2101700000 USD
CY2021Q4 us-gaap Revenues
Revenues
407600000 USD
CY2020Q4 us-gaap Revenues
Revenues
307100000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
334200000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
262900000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
21500000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15500000 USD
CY2021Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1100000 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000 USD
CY2021Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
500000 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2021Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2020Q4 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
300000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
53500000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
29200000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000000.0 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7100000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
40500000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2021Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2020Q4 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
100000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
40500000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
22000000.0 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49700000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48100000 shares
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49700000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48200000 shares
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1015900000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
40500000 USD
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1700000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2021Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
400000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1058400000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
871800000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 USD
CY2020Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
300000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
894100000 USD
CY2021Q4 us-gaap Profit Loss
ProfitLoss
40500000 USD
CY2020Q4 us-gaap Profit Loss
ProfitLoss
22100000 USD
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
800000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
800000 USD
CY2021Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-200000 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2200000 USD
CY2021Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1100000 USD
CY2020Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
200000 USD
CY2021Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
600000 USD
CY2020Q4 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
400000 USD
CY2021Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
500000 USD
CY2020Q4 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
55500000 USD
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
218600000 USD
CY2021Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2600000 USD
CY2020Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2600000 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-12200000 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1000000.0 USD
CY2021Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
12200000 USD
CY2020Q4 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
12600000 USD
CY2021Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6200000 USD
CY2020Q4 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
21100000 USD
CY2021Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
0 USD
CY2020Q4 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
4200000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5800000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-158700000 USD
CY2021Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1500000 USD
CY2020Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
100000 USD
CY2021Q4 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1500000 USD
CY2020Q4 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2100000 USD
CY2021Q4 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
3200000 USD
CY2020Q4 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
0 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3200000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2000000.0 USD
CY2021Q4 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2020Q4 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
100000 USD
CY2021Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2020Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
100000 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-100000 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-200000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8900000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-156900000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153600000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
394300000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
162500000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
237400000 USD
CY2021Q4 us-gaap Notes Issued1
NotesIssued1
0 USD
CY2020Q4 us-gaap Notes Issued1
NotesIssued1
12500000 USD
CY2021Q4 us-gaap Stock Issued1
StockIssued1
1700000 USD
CY2020Q4 us-gaap Stock Issued1
StockIssued1
0 USD
CY2021Q4 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.</span></div>
CY2021Q4 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Presentation and Reclassifications </span></div><div style="text-indent:9pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reclassified the change in accrued development costs from the change in accounts payable and other liabilities to the change in accrued development costs in the prior year statement of cash flows to conform to the current year presentation. This reclassification had no net effect on the Company's consolidated operating results, financial position or cash flows.</span></div>
CY2021Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1960100000 USD
CY2021Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
1905200000 USD
CY2021Q4 us-gaap Payments To Acquire Residential Real Estate
PaymentsToAcquireResidentialRealEstate
135200000 USD
CY2021Q4 us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
244800000 USD
CY2021Q4 for Due Diligence Write Offs
DueDiligenceWriteOffs
600000 USD
CY2020Q4 for Due Diligence Write Offs
DueDiligenceWriteOffs
400000 USD
CY2021Q4 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
3500000 USD
CY2020Q4 us-gaap Other Revenue Expense From Real Estate Operations
OtherRevenueExpenseFromRealEstateOperations
100000 USD
CY2021Q4 us-gaap Revenues
Revenues
407600000 USD
CY2020Q4 us-gaap Revenues
Revenues
307100000 USD
CY2021Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
53700000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
48700000 USD
CY2021Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
8200000 USD
CY2020Q4 us-gaap Interest Costs Incurred
InterestCostsIncurred
11500000 USD
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
9000000.0 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
9200000 USD
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
52900000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
51000000.0 USD
CY2021Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
600000 USD
CY2021Q3 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
700000 USD
CY2021Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
2100000 USD
CY2021Q3 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
400000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7200000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6900000 USD
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
12500000 USD
CY2021Q3 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
15400000 USD
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
10800000 USD
CY2021Q3 us-gaap Deposits Assets
DepositsAssets
10400000 USD
CY2021Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
2000000.0 USD
CY2021Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
5300000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
35200000 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
39100000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
5300000 USD
CY2021Q3 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
7900000 USD
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
600000 USD
CY2021Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
3400000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7700000 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7300000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
7500000 USD
CY2021Q3 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
8500000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3700000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5800000 USD
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
6800000 USD
CY2021Q3 us-gaap Deferred Revenue
DeferredRevenue
6800000 USD
CY2021Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
19900000 USD
CY2021Q3 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
6800000 USD
CY2021Q4 for Letterof Credit Maximum Borrowing Capacity
LetterofCreditMaximumBorrowingCapacity
100000000 USD
CY2021Q4 for Letterof Credit Maximum Borrowing Capacity Percentageof Revolving Credit Commitment
LetterofCreditMaximumBorrowingCapacityPercentageofRevolvingCreditCommitment
0.50
CY2021Q4 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
10200000 USD
CY2021Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
8900000 USD
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1200000 USD
CY2021Q3 us-gaap Other Liabilities
OtherLiabilities
1300000 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
62900000 USD
CY2021Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
56700000 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
704900000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
704500000 USD
CY2021Q4 us-gaap Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
410000000 USD
CY2021Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
600000000 USD
CY2021Q4 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
66300000 USD
CY2021Q4 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
343700000 USD
CY2020Q2 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2021Q4 for Debt Repurchase Program Authorized Amount
DebtRepurchaseProgramAuthorizedAmount
30000000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
40500000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
22000000.0 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
49683369 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48129222 shares
CY2021Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
49500 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
63673 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
49732869 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48192895 shares
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.81
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.46
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.81
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
13000000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7100000 USD
CY2020Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2021Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2021Q4 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
23000000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1200000 USD
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24200000 USD
CY2021Q3 for Deferred Income Tax Liabilities Net Of Deferred Income Tax Assets
DeferredIncomeTaxLiabilitiesNetOfDeferredIncomeTaxAssets
23200000 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1200000 USD
CY2021Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24400000 USD
CY2021Q4 for Equity Securities Registered Value
EquitySecuritiesRegisteredValue
750000000 USD
CY2021Q4 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
300000000 USD
CY2021Q4 for At The Market Equity Offering Program Common Stock Issued
AtTheMarketEquityOfferingProgramCommonStockIssued
84547 shares
CY2021Q4 for At The Market Equity Offering Program Net Proceeds
AtTheMarketEquityOfferingProgramNetProceeds
1700000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
100000 USD
CY2021Q4 for Common Stock Availablefor Issuance Value Remaining
CommonStockAvailableforIssuanceValueRemaining
748200000 USD
CY2021Q4 for At The Market Equity Offering Program Common Stock Available For Issuance
AtTheMarketEquityOfferingProgramCommonStockAvailableForIssuance
298200000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0 shares
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
400000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
300000 USD
CY2021Q4 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
65700 Lot
CY2021Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
66300000 USD
CY2021Q4 us-gaap Special Assessment Bond
SpecialAssessmentBond
528200000 USD
CY2021Q4 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
65700 Lot
CY2021Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
64400 Lot
CY2021Q4 for Numberof Lots Sold
NumberofLotsSold
4516 Lot
CY2020Q4 for Numberof Lots Sold
NumberofLotsSold
3567 Lot
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
162500000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153600000 USD
CY2021Q4 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
65700 Lot
CY2021Q3 us-gaap Number Of Units In Real Estate Property
NumberOfUnitsInRealEstateProperty
64400 Lot

Files In Submission

Name View Source Status
0001406587-22-000010-index-headers.html Edgar Link pending
0001406587-22-000010-index.html Edgar Link pending
0001406587-22-000010.txt Edgar Link pending
0001406587-22-000010-xbrl.zip Edgar Link pending
a12312021exhibit311.htm Edgar Link pending
a12312021exhibit312.htm Edgar Link pending
a12312021exhibit321.htm Edgar Link pending
a12312021exhibit322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
for-20211231.htm Edgar Link pending
for-20211231.xsd Edgar Link pending
for-20211231_cal.xml Edgar Link unprocessable
for-20211231_def.xml Edgar Link unprocessable
for-20211231_htm.xml Edgar Link completed
for-20211231_lab.xml Edgar Link unprocessable
for-20211231_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending